Desvenlafaxine extended release.
Yang
Lily P H
LP
Wolters Kluwer Health | Adis, Auckland, New Zealand. demail@adis.co.nz
Plosker
Greg L
GL
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D003692:Delayed-Action Preparations / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D000069468:Desvenlafaxine Succinate; D004334:Drug Administration Schedule; D006801:Humans; D014179:Neurotransmitter Uptake Inhibitors / Q000627:therapeutic use
D000928:Antidepressive Agents; D003511:Cyclohexanols; D003692:Delayed-Action Preparations; D014179:Neurotransmitter Uptake Inhibitors; D000069468:Desvenlafaxine Succinate